Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

340B Price Setting Policy Should Precede Dispute, Penalty Actions, BIO Urges

Dec 06 2010

• By Cathy Kelly

Related Content

340B Entities Will Continue Fighting For Inpatient Drug Discounts

Apr 26 2010

Can Medicaid Do More To Leverage 340B Drug Pricing? MACPAC May Try To Find Out

Nov 02 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window